Media

• BIO2025: Fit-for-Purpose Manufacturing for Personalized Therapy
  The Pharma Navigator - 11.06.2025
• Limula: Unlocking the full potential of cell therapies with automation
  Verve - 07.06.2025
• Limula’s End-to-End Cell Processing Platform Enters Beta Testing
  GEN Eng News - 06.06.2025
• Personalized therapies are transforming medicine
  globalance - 29.04.2025
• Breakthrough Solution in end-to-end cell therapy manufacturing unveiled
  startup ticket - 07.03.2025
• Limula unveils automated cell therapy tech
  BioProcess International - 03.03.2025
• IMD-connected startups raised CHF 350m in 2024
  IMD - 14.02.2025
• Limula répond aux besoins des thérapies cellulaires
  24heures - 27.05.2024
• Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies
  EU Startups - 21.05.2024
• Biotech Limula secures $6.8M for gene therapy
  tech.eu - 21.05.2024
• Swiss startup creates modular device for on-demand cell therapy manufacturing
  The Next Web - 21.05.2024
• Le vaudois Limula lève 6,2 millions de francs
  agefi - 21.05.2024
• Limula raises $6.8M to scale cell and gene therapies
  startupticker.ch - 21.05.2024
• Saving Lives With Limula’s Machine For Industrializing Cell Therapy
  Forbes - 21.05.2024
• Third LeadiNNg to Scale-Up Cohort unveiled
  startupticker.ch – 13.02.2024
• ZKB Pionierpreis Technopark shortlists 11 startups
  startupticker.ch – 25.01.2024

Previous123Next